- Home
- CLNE vs FBRX Comparison
CLNE vs FBRX Comparison
Compare CLNE & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLNE | FBRX |
|---|---|---|
| Founded | 2001 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 500.3M | 487.2M |
| IPO Year | 2006 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CLNE | FBRX |
|---|---|---|
| Price | $1.73 | $18.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $3.32 | ★ $67.00 |
| AVG Volume (30 Days) | ★ 1.3M | 243.3K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 61.30 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $341,599,000.00 | $36,000.00 |
| Revenue This Year | $1.13 | N/A |
| Revenue Next Year | $22.65 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.72 | $9.12 |
| 52 Week High | $3.11 | $35.80 |
Technical Indicators
Market Signals| Indicator | CLNE | FBRX |
|---|---|---|
| Relative Strength Index (RSI) | 26.38 | 44.08 |
| Support Level | N/A | $17.33 |
| Resistance Level | $2.40 | $22.84 |
| Average True Range (ATR) | 0.08 | 1.22 |
| MACD | -0.02 | 0.46 |
| Stochastic Oscillator | 14.52 | 83.14 |
Price Performance
Historical ComparisonAbout CLNE Clean Energy Fuels Corp.
Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas and liquefied natural gas for the United States (U.S.) and Canadian transportation markets. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The firm operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. It also builds, operates, and maintains natural gas fueling stations for customers.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.